ArticleObesity surgery2026
Elastic Intracorporeal Retraction in Laparoscopic Bariatric Surgery: Performance, Safety, and Multi-Organ Applications.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEffective organ retraction is essential for safe minimally invasive bariatric surgery. Traditional retraction techniques have notable limitations: rigid external retractors require subxiphoid incisions and are associated with hepatic trauma and biochemical liver injury, while handheld retractors require additional trocars, increasing complications and operative time. The Elastic Intracorporeal Retractor (EICR) was developed as a trocar-free, hands-free multi-organ retraction system.
objectivesTo evaluate the intraoperative performance, technical feasibility, and safety of the EICR in consecutive laparoscopic bariatric procedures.
settingTertiary care center.
methodsThis retrospective study included 96 consecutive procedures performed between January 2022 and January 2025 by a single surgeon. The EICR (XNY Medical) was deployed through a standard 10-mm trocar. Primary outcomes included technical performance (first-attempt deployment, insertion time, repositioning). Secondary outcomes assessed safety through intraoperative events and 30-day outcomes. Independent blinded video review by an external surgeon evaluated 40 consecutive cases.
resultsThe EICR achieved first-attempt deployment in 99% of cases, with median insertion time of 95 s (IQR 75-115). Repositioning occurred in 10.4%; no additional retraction trocars were required in any case. The device was used for liver retraction in 89.6% of cases, with retraction of a structure other than the liver in 8 of 96 patients (8.3%): the oesophagus in 7 and the greater omentum in 1. Minor retraction-related complications occurred in 5.2% (four serosal tears <5 mm, one hook disconnection), all managed conservatively. Liver function tests in complication cases were within normal limits; systematic cohort-wide testing was not performed. No major complications, conversions, or reoperations occurred. Independent blinded review demonstrated complete concordance with documented outcomes.
conclusionsAcross 96 consecutive procedures with independent blinded video validation, the EICR provided reliable, reproducible organ retraction with a rapid deployment time, an acceptable intraoperative safety profile, and no requirement for additional retraction trocars. Retraction was also achieved beyond the liver in 8 of 96 patients (oesophagus, 7; greater omentum, 1). As an uncontrolled single-surgeon series, this study demonstrates feasibility; comparative effectiveness against existing retraction methods now warrants prospective controlled evaluation.
Indexed as
Identifiers
42702665What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.